WebSep 22, 2024 · EMERYVILLE, Calif., September 22, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: WebJul 1, 2024 · NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the …
NovaBay Pharmaceuticals LinkedIn
WebThis International Distribution Agreement (the “Agreement”) is effective as of the 9th day of January, 2012 (the “Effective Date”) by and between Pioneer Pharma Co. Ltd., with its principal place of business at Suite A-C 18F, HuDong Finance Building, No.1128, XiangYin Road, Shanghai, P.R.C. (“Pioneer”) and NovaBay Pharmaceuticals, Inc., a Delaware … WebMay 14, 2024 · NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the … church awards certificates
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE
WebMar 30, 2024 · Net product revenue for the fourth quarter of 2024 was $3.6 million, an increase of 15% from $3.2 million for the prior-year period, and included $2.1 million of Avenova-branded product sales, $1.0 million of DERMAdoctor product sales and $0.1 million of PhaseOne ® and $0.3 million of NeutroPhase ® branded wound care product sales. WebApr 11, 2024 · NovaBay Pharmaceuticals Stock Down 1.3 % NBY opened at $1.58 on Tuesday. NovaBay Pharmaceuticals has a 52 week low of $1.24 and a 52 week high of $12.64. The business has a 50 day moving... WebCompany Description: NovaBay Pharmaceuticals aims to keep the "bed bugs" away. The clinical-stage biopharmaceutical company develops antimicrobial compounds (known as … detox naturally uk